Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials

(2019) Daniel E. Falk et al.   JAMA Psychiatry

Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population

(2019) Justin Knox et al.   DRUG AND ALCOHOL DEPENDENCE

Course of remission from and relapse to heavy drinking following outpatient treatment of alcohol use disorder

(2018) Stephen A. Maisto et al.   DRUG AND ALCOHOL DEPENDENCE

Drinking Goal Trajectories and Their Association with Client Characteristics and Outcomes among Clients in Outpatient Alcohol Treatment

(2018) Severin Haug et al.   SUBSTANCE USE & MISUSE

Effects of the Opioid System Modulator, Samidorphan, on Measures of Alcohol Consumption and Patient-Reported Outcomes in Adults with Alcohol Dependence

(2018) Stephanie S. O'Malley et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Reduction in non-abstinent WHO drinking risk levels and change in risk for liver disease and positive AUDIT-C scores: Prospective 3-year follow-up results in the US general population

(2018) Justin Knox et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder

(2018) Katie Witkiewitz et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?

(2017) Karl Mann et al.   EUROPEAN ADDICTION RESEARCH

Missing Data in Alcohol Clinical Trials with Binary Outcomes

(2016) Kevin A. Hallgren et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels

(2016) Katie Witkiewitz et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

(2016) Paul Y Kwo et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Is the Construct of Relapse Heuristic, and Does It Advance Alcohol Use Disorder Clinical Practice?

(2016) Stephen A. Maisto et al.   Journal of Studies on Alcohol and Drugs

A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence

(2016) Megan L Ryan et al.   NEUROPSYCHOPHARMACOLOGY

Clinical Relevance of As-Needed Treatment with Nalmefene in Alcohol-Dependent Patients

(2015) Henri-Jean Aubin et al.   EUROPEAN ADDICTION RESEARCH

Predictors of Pretreatment Commitment to Abstinence: Results from the COMBINE Study

(2015) Kelly S DeMartini et al.   Journal of Studies on Alcohol and Drugs

Methods to Analyze Treatment Effects in the Presence of Missing Data for a Continuous Heavy Drinking Outcome Measure When Participants Drop Out from Treatment in Alcohol Clinical Trials

(2014) Katie Witkiewitz et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Missing Data in Alcohol Clinical Trials: A Comparison of Methods

(2013) Kevin A. Hallgren et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence

(2013) Jan van Amsterdam et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use Disorders

(2011) Raymond F Anton et al.   NEUROPSYCHOPHARMACOLOGY